C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/4545 (2006.01) C07D 413/04 (2006.01)
Patent
CA 2570197
A compound having the general structure shown in Formula (I) or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
L'invention concerne un composé dont la structure générale est représentée par la formule (I) ou des sels pharmaceutiquement acceptables et solvates dudit composé, qui peuvent traiter utilement des maladies ou des états induits par les récepteurs de NK1, par exemple divers troubles physiologiques, symptômes ou maladies, dont le vomissement, la dépression, l'anxiété et la toux.
Huang Xianhai
Palani Anandan
Paliwal Sunil
Rao Ashwin U.
Shah Sapna S.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Opko Health Inc.
Schering Corporation
LandOfFree
Piperidine derivatives as nk1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivatives as nk1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives as nk1 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1952998